Aricept (Alzheimer’s disease) – Analysis and Forecasts to 2022
Aricept (Alzheimer’s disease) – Analysis and Forecasts to 2022 Summary GlobalData’s pharmaceuticals report, “Aricept (Alzheimer’s disease) – Analysis and Forecasts to 2022” provides Aricept global...
View ArticleNamenda (Alzheimer’s disease) – Analysis and Forecasts to 2022
Namenda (Alzheimer’s disease) – Analysis and Forecasts to 2022 Summary GlobalData’s pharmaceuticals report, “Namenda (Alzheimer’s disease) – Analysis and Forecasts to 2022” provides Namenda global...
View ArticleGammagard Liquid (Alzheimer’s disease) – Analysis and Forecasts to 2022
Gammagard Liquid (Alzheimer’s disease) – Analysis and Forecasts to 2022 Summary GlobalData’s pharmaceuticals report, “Gammagard Liquid (Alzheimer’s disease) – Analysis and Forecasts to 2022” provides...
View ArticleLY2062430 (Alzheimer’s disease) – Analysis and Forecasts to 2022
LY2062430 (Alzheimer’s disease) – Analysis and Forecasts to 2022 Summary GlobalData’s pharmaceuticals report, “LY2062430 (Alzheimer’s disease) – Analysis and Forecasts to 2022” provides LY2062430...
View ArticleDementia – Pipeline Review, H1 2012
Dementia – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Dementia - Pipeline Review, H1 2012', provides an overview of the Dementia therapeutic pipeline. This report provides information...
View ArticleDementia Global Clinical Trials Review, H2, 2012
Dementia Global Clinical Trials Review, H2, 2012 Summary GlobalData's clinical trial report, “Dementia Global Clinical Trials Review, H2, 2012" provides data on the Dementia clinical trial scenario....
View ArticleDementia – Pipeline Review, H2 2012
Dementia – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Dementia - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides...
View ArticleDementia Partnering 2007-2012 - Edition 1
The Dementia Partnering 2007-2012 report provides understanding and access to the dementia partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in dementia...
View ArticleDementia Partnering 2007-2013 Edition: 1 Code: CP2204dem
The Dementia Partnering 2007-2013 report provides understanding and access to the dementia partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in dementia...
View ArticleDementia – Pipeline Review, H1 2013
Dementia – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Dementia - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...
View ArticleDementia Partnering 2007-2013 Edition: 1
Summary:The Dementia Partnering 2007-2013 report provides understanding and access to the dementia partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in...
View ArticleDementia Global Clinical Trials Review, H2, 2013
Dementia Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Dementia Global Clinical Trials Review, H2, 2013" provides data on the Dementia clinical trial scenario....
View ArticleDementia Partnering 2009-2014 (CP2204dem Edition: 1)
The Dementia Partnering 2009-2014 provides understanding and access to the dementia partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an...
View ArticleDementia - Pipeline Review, H1 2015
Dementia - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Dementia - Pipeline Review, H1 2015’, provides an overview of the Dementia’s therapeutic pipeline. This report provides...
View Article
